Macías-Barragán José, Montoya-Buelna Margarita, Enciso-Vargas Moisés, Alvarado-Ruíz Liliana, Oceguera-Contreras Edén, Guerra-Renteria Aracely Suggey, Graciano-Machuca Omar
Laboratorio de Sistemas Biológicos, Departamento de Ciencias de la Salud, Centro Universitario de los Valles (Cuvalles), Universidad de Guadalajara (UDG), Ameca, México.
Laboratorio de Inmunología, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, UDG, Guadalajara, México.
Immunol Invest. 2022 Apr;51(3):480-495. doi: 10.1080/08820139.2020.1840582. Epub 2020 Oct 29.
Psoriasis (Ps) is an autoimmune dermatosis. Previous studies have shown an association between genes and susceptibility to some clinical variants of Ps. Therefore, we conducted an exhaustive systematic review with meta-analysis to evaluate the relationship between genes and susceptibility to clinical variants of Ps in the overall population and according to ethnicity.
According to PRISMA guidelines, we performed a systematic review through PubMed and Web of Science to identify relevant available scientific publications about genes and Ps. The quality of the studies was evaluated using the Newcastle-Ottawa scale. Odds ratios (OR) and 95% confidence intervals (95%CI) were estimated using random and fixed effect models for the analyzed genes. Heterogeneity was tested using Cochran's -Statistic and I, and the risk of bias was tested using the Begg test and Egger linear regression.
A total of 10 case-control studies were included, comprising a variable number of typified genes and psoriasis vulgaris (PsV) as the main clinical variant studied. In the total pooled results, the gene (OR = 1.518, = .010, 95%CI: 1.105 to 2.086) was related to higher susceptibility to PsV, while the (OR = 0.563, = .005, 95%CI: 0.376 to 0.842) and (OR = 0.602, = .040, 95%CI: 0.370 to 0.977) genes were related to protection against PsV.
This meta-analysis demonstrates that subjects that carry the gene could have a potential risk factor for the development of PsV. Conversely, and genes appear to confer protection against PsV.
银屑病(Ps)是一种自身免疫性皮肤病。先前的研究表明,某些基因与银屑病的一些临床变异型易感性之间存在关联。因此,我们进行了一项详尽的系统评价并进行荟萃分析,以评估在总体人群中以及按种族划分时,这些基因与银屑病临床变异型易感性之间的关系。
根据PRISMA指南,我们通过PubMed和Web of Science进行了系统评价,以识别有关这些基因和银屑病的相关可用科学出版物。使用纽卡斯尔-渥太华量表评估研究质量。对于分析的基因,使用随机和固定效应模型估计比值比(OR)和95%置信区间(95%CI)。使用 Cochr an's Q统计量和I²检验异质性,并使用Begg检验和Egger线性回归检验偏倚风险。
共纳入10项病例对照研究,包括数量可变的典型基因,寻常型银屑病(PsV)为主要研究的临床变异型。在总的合并结果中,该基因(OR = 1.518,P = 0.010,95%CI:1.105至2.086)与PsV的较高易感性相关,而该基因(OR = 0.563,P = 0.005,95%CI:0.376至0.842)和该基因(OR = 0.602,P = 0.040,95%CI:0.370至0.977)与预防PsV相关。
这项荟萃分析表明,携带该基因的受试者可能是PsV发生的潜在危险因素。相反,该基因和该基因似乎赋予对PsV的保护作用。